Peripheral vascular disease and serum phosphorus in hemodialysis: A nested case-control study

Clinical Nephrology

Volumn 63, Issue 2, 2005, Pages 98-105

  Boaz, M ^a,b   Weinstein, T ^b   Matas, Z ^a   Green, M S ^b,c   Smetana, S ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

^b HASHARON HOSPITAL   (Israel)

^c Israel Center for Disease Control   (Israel)

Author keywords

Calcium; Hemodialysis; Peripheral vascular disease; Phosphorus

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COLECALCIFEROL; ERYTHROPOIETIN; PHOSPHATE BINDING AGENT; PHOSPHORUS;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PHOSPHATE BLOOD LEVEL; PREDICTION; PRESCRIPTION; RISK FACTOR; SECONDARY PREVENTION; SMOKING;

EID: 14544299242     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63098     Document Type: Article

References (29)

1. Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E 1995 Blood pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. Nephrol Dial Transplant 10: 2043-1048
2. Amann K, Tornig J, Kugel B, Gross M, Tyralla K, El-Shakmak A, Szabo A, Ritz E 2003 Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63: 1296-1301
3. Bird RP, Draper HH 1984 Comparative studies on different methods of malondialdehyde determination. Methods Enzymol 105: 299-305
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM 2001 Arterial calcifications, arterial stiffness and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK 1998 Association of serum phosphorus and calcium × phosphorus product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617
6. Block GA, Port FK 2000 Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35: 1226-1237
7. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS 2000 Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218
8. Bommer J, Strohbeck E, Georish J, Bahner M, Zuna I 1996 Arteriosclerosis in dialysis patients. Int J Artif Organs 19: 638-644
9. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Left FC 1996 Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 27: 392-401
10. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS 2000 Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362
11. Dormandy J, Heeck L, Vig S 1999 Predictors of early disease in the lower limbs. Semin Vasc Surg 12: 109-117
12. Daugirdas JT 1993 Second-generation logarithmic estimates of single-pool variable volume Kt/V, an analysis of error. J Am Soc Nephrol 4: 1205-1213
13. Goldsmith DJA, Covic A, Sambrook PA, Ackrill P 1997 Vascular calcification in long-term hemodialysis patients in a single unit: a retrospective analysis. Nephron 77: 37-43
14. Goodman WG, Goldin J, Kuizon B, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff R, Salusky I 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483
15. Gutteridge JM, Stocks J 1976 Automated colorimetric method for the determination of serum tocopherol. Lab Pract 25: 25-27
16. Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, Inaba M, Nishizawa Y 2002 Different risk factors for peripheral vascular calcification between diabetic and nondiabetic haemodialysis patients - importance of glycaemic control. Diabetologia 45: 1446-1448
17. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Shoji T, Tabata T, Inoue T, Morii H 1995 High resolution B mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48: 820-826
18. Levin NW, Hulberg-Shearon TE, Strawderman RL, Port FK 1998 Which causes of death are related to hyperphosphatemia in hemodialysis patients? J Am Soc Nephrol 9: 217A
19. Mazzaferro S, Coen G, Bandini S, Borgatti PP, Ciaccheri M, Diaciniti D, Ferranti E, lusenti T, Mancini G, Monducci I, Pasquali M, Pellegrini F, Perrucca I, Taggi F, Cinotti GA 1993 Role of aging, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 8: 335-340
20. Milliner DS, Zinsmeister AR, Lieberman E, Landing B 1990 Softtissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38: 931-936
21. Naveh-Many T, Rahamimov R, Livni N, Silver J 1995 Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 1786-1793
22. Nishizawa Y, Shoji T, Kawagishi T, Morii H 1997 Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int 52 (Suppl 62): S90-S92
23. O'Hare AM, Hsu CY, Baccheti P, Johanssen K 2002 Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 13: 497-503
24. O'Hare AM, Bacchetti P, Segal M, Hsu CY, Johansen KL 2000 Dialysis Morbidity and Mortality Study Waves Factors associated with future amputation among patients undergoing hemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4. Am J Kidney Dis 41: 162-170
25. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ 2000 Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 49: 1571-1578
26. Ribeiro S, Ramos A, Brandao A, Rebelo J, Guerra A, Resina C, Pila-Lobos A, Carvacho F, Remedio F, Rireird F 1998 Cardiac Valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 13: 2037-2040
27. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG 1988 Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85: 651-657
28. Rostand SG, Drueke TB 1999. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56: 383-392
29. Slatopolsky E, Dusso A, Brown AJ 1999 The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure. Am J Med Sci 317: 370-376